Abstract Details
|
Marinos G. Sotiropoulos, MD
(Massachusetts General Hospital)
PRESENTER |
Dr. Sotiropoulos has or had stock in Moderna.Dr. Sotiropoulos has or had stock in Ikena Oncology.Dr. Sotiropoulos has or had stock in Cassava Sciences.Dr. Sotiropoulos has or had stock in Biogen.Dr. Sotiropoulos has or had stock in Tiziana Life Sciences.Dr. Sotiropoulos has received publishing royalties from a publication relating to health care. |
| Prashanth Rajarajan, MD, PhD (Brigham and Women's Hospital) | Dr. Rajarajan has nothing to disclose. |
| Cameron Hayes | Mr. Hayes has nothing to disclose. |
| Michael Bowley, MD (Massachusetts General Hospital) | Dr. Bowley has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for DeLUCA, WEIZENBAUM, BARRY & REVENS, LTD.. Dr. Bowley has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hamilton Weber LLC. |
| Christopher T. Doughty, MD (Brigham and Women'S Hospital) | Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurometrix. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Doughty has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TD Securities. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Adler¦Cohen¦Harvey¦Wakeman¦Guekguezian, LLP. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gidley, Sarli & Marusak, LLP. Dr. Doughty has received research support from NINDS/NeuroNEXT. Dr. Doughty has received research support from AstraZeneca. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a Grant Advisory Board Member with Dysimmune Diseases Foundation. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a CME Lecturer with Oakstone Publishing. |